EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, J. L.
Right arrow Articles by Fisher, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, J. L.
Right arrow Articles by Fisher, J. S.
Experimental Biology and Medicine 230:845-852 (2005)
© 2005 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Possibility of Autocrine ß-Adrenergic Signaling in C2C12 Myotubes

Jill L. Smith*, Pankaj B. Patil*, Shelley D. Minteer{dagger}, Jason R. Lipsitz* and Jonathan S. Fisher*,1

* Department of Biology and {dagger} Department of Chemistry, Saint Louis University, St. Louis, Missouri 63103

To whom requests for reprints should be addressed at 1 Department of Biology, Saint Louis University, 3507 Laclede Avenue, St. Louis, MO 63103. E-mail: fisherjs{at}slu.edu

Levodopa reportedly inhibits insulin action in skeletal muscle. Here we show that C2C12 myotubes produce levodopa and that insulin-stimulated glucose transport is enhanced when endogenous levodopa is depleted. Exogenous levodopa prevented the stimulation of glucose transport by insulin (P < 0.05) and increased cAMP concentrations (P < 0.05). The decrease in insulin-stimulated glucose transport caused by levodopa was attenuated by propranolol (a ß-adrenergic antagonist) and prevented by NSD-1015 (NSD), an inhibitor of DOPA decarboxylase (DDC; converts levodopa to dopamine). Propranolol and NSD both prevented levodopa-related increases in [cAMP]. However, the effects of levodopa were unlikely to be dependent on the conversion of levodopa to catecholamines because we could detect neither DDC in myotubes nor catecholamines in media after incubation of myotubes with levodopa. The data suggest the possibility of novel autocrine ß-adrenergic action in C2C12 myotubes in which levodopa, produced by myotubes, could have hormone-like effects that impinge on glucose metabolism.

Key Words: excitatory amino acid • DOPA • GLUT4 • myotubes • tyrosine hydroxylase




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Park, T. L. Scheffler, A. M. Gunawan, H. Shi, C. Zeng, K. M. Hannon, A. L. Grant, and D. E. Gerrard
Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle
Am J Physiol Cell Physiol, January 1, 2009; 296(1): C106 - C115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J.-S. Ju, M. A. Gitcho, C. A. Casmaer, P. B. Patil, D.-G. Han, S. A. Spencer, and J. S. Fisher
Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C564 - C572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Experimental Biology and Medicine.